East Bay Dermatology’s Post

Learn about the types of non-melanoma skin cancers, potential treatments and side effects, clinical trials and the emotional concerns of a diagnosis from a Mindful Dermatology Physicians Assistant. Please register by May 7 here: https://lnkd.in/gE7NbYpz

Today is European Skin Cancer Prevention Day! A day to raise awareness, as leaders in dermatology, about the effects of skin cancer. Skin cancer, diagnosed in its earliest stages, can exponentially increase long-term survival rates in patients. It is our duty, as professionals in the field, to help prevent its incidence. At ISD, we offer a comprehensive platform to all professionals in the dermatology field, ensuring they stay informed about industry advancements and incorporate cutting-edge insights into their practice. #ISD #InternationalSchoolDerma #EuropeanSkinCancerPreventionDay

If you want to learn more about how GEP testing can guide management in patients with ambiguous melanocytic lesions, check out this recorded webinar! Alexander Witkowski MD, PhD details how he has incorporated this test into his dermatology practice to achieve clinicopathological correlation and more precise patient management plans.

Dermatologists learn how this can be used in your practice:

About 9,500 people in the U.S. are diagnosed with skin cancer every day, according to the American Academy of Dermatology Association, and 90% of those diagnosed with nonmelanoma skin cancer developed it from exposure to ultraviolet rays. Since July is UV Safety Month, we offer reminders of how to enjoy the sun safely and additional information for anyone concerned about certain spots they’ve seen on themselves or a loved one. Explore our Well-th & Well-being page for additional resources. https://lnkd.in/eeBF_-i3 #uvsafety #skincancer #wellthandwellbing #wellnessresources #sunsafety

In case you missed it: Watch the Dermatology Authority webinar showcasing MyPath Melanoma Tune in to learn about "Integrating 23-GEP Testing (MyPath Melanoma) with Dermoscopy and Histopathology in challenging melanocytic lesions" here: https://hubs.la/Q02lNrPR0

Long-term clinical trial results from a JAK inhibitor in #AlopeciaAreata (AA) patients, which includes integrated efficacy (through 104 weeks) and safety (up to 3.6 years) data, are published in the Journal of the European Academy of Dermatology and Venereology. Learn about long-term treatment results of severe AA with a JAK inhibitor in this manuscript: https://e.lilly/3SV3OD3

This review focuses on determining the implementation of dermoscopy and if this technique can help improve the accuracy, specificity, and sensitivity rates of skin cancer. Read more: https://ow.ly/nho750TyV5l Kathryn Harrison DMSc, MMS, PA-C, Dermatology CAQ

I am delighted to share my recent publication on the use of dermosopy to improve the accuracy of cutaneous malignancy diagnosis!

Ophthopedia Update:Blastic Plasmacytoid Dendritic Cell Neoplasm with ocular infiltration: A 62-year-old male patient presented to the Dermatology clinic with a 6-month history of progressive nodulo-tumoral skin lesions (Figure 1) and cytopenias. He had an elevated subconjunctival mass next to the caruncle of the left eye measuring approximately 1cm at its largest extension clinically similar to skin lesions (Figure 2). Skin biopsy was performed and showed a dense dermal infiltrate composed of blast-like cells (Figure 3) that were positive on immunohistochemistry for CD123, CD4 and CD56. #Ophthalmology #Ophthotwitter #Scicomm